| Completed | 4 | 232 | RoW | Qsymia 3.75Mg-23Mg Extended Release Capsule, Low dose titration, Qsymia 7.5Mg-46Mg Extended Release Capsule, Low dose maintenance, Qsymia 11.25Mg-69Mg Extended Release Capsule, High dose titration, Qsymia 15Mg-92Mg Extended Release Capsule, High dose maintenance, Placebo | Alvogen Korea | Obesity | 10/23 | 10/23 | | |
NCT05226897: Clinical Trial to Assess the Efficacy and Safety of YYC405 in Type 2 Diabetes Patients |
|
|
| Active, not recruiting | 3 | 256 | RoW | YYC405-T, Metforminâ„1000mg, Dapagliflozin 10mg, YYC405-T placebo | Yooyoung Pharmaceutical Co., Ltd. | Type 2 Diabetes | 10/22 | 06/23 | | |